Technical Consultative Meeting on the EM Regional COVID-19 Vaccine Effectiveness Study – Day 1 (12 November 2022)
Presentations
Meeting Objectives and Introduction of Participants
Evaluation of VE for COVID-19 Vaccine in the American Region
Overview of the EM Regional COVID-19 VE Study & Establishment of the EM Regional COVID-19 VE Network
COVID-19 VE against Severe Acute Respiratory Infections (SARI) Test Negative Design
Notable COVID-19 vaccine studies in KSA
Vaccine effectiveness in hcw at tertiary care hospitals of kp, pakistan: a cohort study
COVID-19 vaccine effectiveness studies: The experience in Qatar
Technical Consultative Meeting on the EM Regional COVID-19 Vaccine Effectiveness Study – Day 2
Presentations
Recap of first day’s sessions: summary of key points
Adapting existing SARI/ILI surveillance platforms for influenza to advance in COVID-19 response
Global update on COVID-19 vaccine effectiveness studies during Omicron
Large-scale national studies and evidence-informed policy-making
Vaccination and COVID-19 in Morocco
Regional agenda to support institutionalization of evidenceinformed policy-making for health
Capacity building workshop for the "WHO EMRO COVID-19 vaccine effectiveness study: status update and important considerations" – Day 1, November 2022
Day 1 – Recording of workshop
Day 2– Recording of workshop
Day 1 – Presentations
Conducting COVID-19 VE Studies What Next for Policy-making
Covid-19 Vaccine Effectiveness (VE) updates from HQ
Antibody Testing for SARS-CoV-2 and use in VE Studies
EMR COVID-19 Vaccine Effectiveness Network: Challenges and the Way Forward
EMR COVID-19 Vaccine Effectiveness Study – Status Update
Role of National Immunization Technical Advisory Groups (NITAG) in COVID-19 VE studies in the Region
Day 2 – Presentations
Recap of the First Day of Workshop
Methods to confirm SARS-CoV-2 infections in VE studies
Use of Electronic Health Registries to Estimate COVID-19 VE The Experience of Qatar
COVID-19 and Influenza VE Studies in the WHO European Region: Operational Challenges and Preliminary Results
COVID 19 VEs studies Updated guidance - on study design and bias
Session 1: Interactive capacity-building session on using REDCap for data management in the regional COVID-19 VE study: test-negative design in severe acute respiratory infection (SARI) and cohort study in health care workers methods – March 2022
Presentations
Interactive Capacity-Building Training Session Using REDCap for Data Management
Session 2: REDCap in the regional COVID-19 vaccine effectiveness studies: test-negative design in the severe acute respiratory infection method - March 2022
Presentations
Test-Negative Design (TND) in Severe Acute Respiratory Infection (SARI)
Session 3: REDCap in the regional COVID-19 vaccine effectiveness studies: cohort study in health care workers - March 2022
Presentations
Capacity-building session for Eastern Mediterranean regional COVID-19 vaccine effectiveness study; using cohort study in health care workers’ method: December 2021
Presentations
COVID-19 Vaccine Effectiveness in Health Workers (HW)
Minimum criteria and checklist of requirements for countries
Post-Introduction COVID-19 Vaccine Effectiveness Studies Among Healthcare Workers in the European Region
Support for COVID-19 vaccine effectiveness studies in EMR countries: evidence generation for immunization policymaking
Vaccine effectiveness studies to guide immunization policies
Capacity-building session for Eastern Mediterranean regional COVID-19 vaccine effectiveness study; using test-negative design in severe acute respiratory infection (SARI) method: December 2021
Presentations
COVID-19 Vaccine Effectiveness in Severe Acute Respiratory Infection (SARI) Cases
2021 COVID-19 vaccine effectiveness against hospitalisation due to laboratory-confirmed SARS-CoV-2 infection in older adults: pre-Delta and Delta periods Pooled results from nine European countries
Existing SARI Surveillance Systems for Influenza and Integration with SARS-CoV-2 Surveillance in the EMR
Minimum criteria and checklist of requirements for countries
Support for COVID-19 vaccine effectiveness studies in EMR countries: evidence generation for immunization policymaking
